Skip to content

Apnimed, Inc.

APMD· Nasdaqxbrl foundCIK 1745648

Pharmaceutical preparations552 peers

Last sale
Nov 12, 2026 · -0.27%
Market cap
$694.61M
41.63M shares
Filings
61
$12.08M
Q2 2026
—
$125.94M
Q2 2026
—
-$11.70M
Q2 2026
—
—
—
—
$3.41
Q2 2026
—
$172.80M
Q2 2026
—
$694.61M
—
—
—
—
—

FY2026 figures · derived

Price

$16.6933.26%$8.32since Jul 31, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$12.08MQ2 2026
No annual history for this metric yet.
PeriodEndedValueKindSource trail

Pharmaceutical preparations

Apnimed, Inc. is the 162nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Apnimed, Inc. · CIK 1745648 · Engraved from SEC EDGAR